Three-year Effectiveness in Patients with JIA Initiating Abatacept: Results from the PRCSG/PRINTO JIA Real-World Registry

被引:0
|
作者
Ruperto, Nicolino [1 ,2 ]
Brunner, Hermine [3 ]
Tzaribachev, Nikolay [4 ]
Orban, Ilonka [5 ]
Stanevica, Valda [6 ]
del Rio, Ana Quintero [7 ]
Quartier, Pierre [8 ]
Huber, Adam [9 ]
Kietz, Dan [10 ]
Dare, Jason [11 ]
Kingsbury, Daniel [12 ]
Graham, T. Brent [13 ]
Foeldvari, Ivan [14 ]
Patel, Julisa [15 ]
Dominique, Alyssa [16 ]
Dong, Lixian [16 ]
Kou, Tzuyung Douglas [16 ]
Wong, Robert [17 ]
Martini, Alberto [18 ]
Lovell, Daniel [19 ]
机构
[1] IRCCS Ist Giannina Gaslini, Genoa, Italy
[2] PRINTO, Clin Pediat & Reumatol, Genoa, Italy
[3] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[4] PRI Res, Bad Bramstedt, Germany
[5] Natl Inst Rheumatism & Physiotherapy, Budapest, Hungary
[6] Riga Stradins Univ, Riga, Latvia
[7] Dr Ramon Ruiz Arnau Univ Hosp, Bayamon, PR USA
[8] Necker Enfants Malades Univ Hosp, AP HP, Paris, France
[9] Dalhousie Univ, Halifax, NS, Canada
[10] Childrens Hosp Pittsburgh, Pittsburg, KS USA
[11] Univ Arkansas Med Sci, Little Rock, AR 72205 USA
[12] Randall Childrens Hosp Legacy Emanuel, Portland, OR USA
[13] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[14] Hamburg Ctr Pediat & Adolescent Rheumatol, Hamburg, Germany
[15] Augusta Univ, Childrens Hosp Georgia, Med Ctr, Augusta, GA USA
[16] Bristol Myers Squibb, Princeton, NJ USA
[17] Bristol Myers Squibb, Basking Ridge, NJ USA
[18] Paediat Rheumatol Int Trials Org PRINTO, Genoa, Italy
[19] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0247
引用
收藏
页码:500 / 502
页数:3
相关论文
共 50 条
  • [21] Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registry
    Armaroli, Giulia
    Klein, Ariane
    Ganser, Gerd
    Ruehlmann, Michael J.
    Dressler, Frank
    Hospach, Anton
    Minden, Kirsten
    Trauzeddel, Ralf
    Foeldvari, Ivan
    Kuemmerle-Deschner, Jasmin
    Weller-Heinemann, Frank
    Urban, Andreas
    Horneff, Gerd
    ARTHRITIS RESEARCH & THERAPY, 2020, 22 (01)
  • [22] Real-world effectiveness of fremanezumab in migraine patients initiating treatment in the United States: results from a retrospective chart study
    Maurice T. Driessen
    Joshua M. Cohen
    Oscar Patterson-Lomba
    Stephen F. Thompson
    Michael Seminerio
    Karen Carr
    Todor I. Totev
    Rochelle Sun
    Erica Yim
    Fan Mu
    Rajeev Ayyagari
    The Journal of Headache and Pain, 2022, 23
  • [23] Real-world effectiveness of fremanezumab in migraine patients initiating treatment in the United States: results from a retrospective chart study
    Driessen, Maurice T.
    Cohen, Joshua M.
    Patterson-Lomba, Oscar
    Thompson, Stephen F.
    Seminerio, Michael
    Carr, Karen
    Totev, Todor, I
    Sun, Rochelle
    Yim, Erica
    Mu, Fan
    Ayyagari, Rajeev
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01):
  • [24] Two- and Three-Year Outcomes from the Childhood Arthritis and Rheumatology Research Alliance Start Time Optimization of Biologic Therapy in Polyarticular JIA (STOP-JIA) Study
    Ringold, Sarah
    Tomlinson, George
    Schanberg, Laura
    del Gaizo, Vincent
    Murphy, Katherine
    Feldman, Brian
    Ong, Mei-Sing
    Natter, Marc
    Kimura, Yukiko
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1664 - 1666
  • [25] Characteristics of patients treated for CLL in a real-world registry: results from informCLL™
    Mato, Anthony
    Sharman, Jeff
    Pagel, John
    Brander, Danielle
    Kadish, Karen
    Tomlinson, Brian
    Ipe, David
    Yang, Huiying
    Arango-Hisijara, Israel
    Srivastava, Bhavini
    Schenkel, Brad
    Barrientos, Jacqueline
    LEUKEMIA & LYMPHOMA, 2017, 58 : 48 - 49
  • [26] Three-year real-world data in fingolimod treatment: the effects on cognitive function
    Ozakbas, S.
    Cinar, B. Piri
    Yigit, P.
    Kahraman, T.
    Kosehasanogullari, G.
    Mehdiyev, Z.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 288 - 289
  • [27] Three-year efficacy of switching to dolutegravir plus lamivudine: A real-world study
    Palmier, E.
    De Miguel, R.
    Montejano, R.
    Busca, C.
    Mican, R.
    Ramos, L.
    Cadinanos, J.
    Serrano, L.
    Bernardino, J. I.
    Perez-Valero, I.
    Valencia, E.
    Arribas, J. R.
    Montes, M. L.
    Gonzalez-Garcia, J.
    Martin-Carbonero, L.
    HIV MEDICINE, 2023, 24 (09) : 1013 - 1019
  • [28] Abatacept retention and clinical effectiveness in patients with rheumatoid arthritis in a real-world setting in Taiwan
    Chen, Kun-Hung
    Li, Ko-Jen
    Fang, Yao-Fan
    Hsieh, Song-Chou
    Chen, Ying-Chou
    Lee, Chyou-Shen
    Luo, Shue-Fen
    Cheng, Tien-Tsai
    Tsai, Wen Chan
    Lo, Yu-Chen
    Lan, Joung-Liang
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (07)
  • [29] Baseline characteristics of patients with asthma initiating dupilumab in a real-world setting: the RAPID registry
    Lugogo, Njira
    Peters, Anju T.
    Cote, Andreanne
    Hilberg, Ole
    Heffler, Enrico
    Munoz, Xavier
    Vinge, Ines
    Mansur, Adel H.
    Nagase, Hiroyuki
    Shao, Liyang
    Yarbrough, Lauren
    Gomez, Lucia De Prado
    Jacob-Nara, Juby
    Sacks, Harry
    Rowe, Paul J.
    Deniz, Yamo
    Bourdin, Arnaud
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [30] Real-World Effectiveness of Dupilumab Through 18 Months in Patients with CRSwNP and AERD: Results from the Global AROMA Registry
    White, Andrew
    Buchheit, Kathleen
    Laidlaw, Tanya
    Heffler, Enrico
    Cornet, Marjolein
    Xia, Changming
    Kim, Helen
    Corbett, Mark
    Jacob-nara, Juby
    Radwan, Amr
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2025, 155 (02) : AB302 - AB302